VIDEO: AccuraSee intraocular pseudophakic contact lens investigated in AMD
Click Here to Manage Email Alerts
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Kevin J. Cady of OnPoint Vision provides an update on the AccuraSee intraocular pseudophakic contact lens.
The idea behind the lens is to fine-tune refractive error in patients who have already undergone cataract surgery, but the first-generation model addresses age-related macular degeneration, with the company entering into a phase 1 trial.
“The outcomes are looking promising,” Cady said. “We are gaining five to six lines of vision for patients, essentially, you could categorize as going blind. Patients are now able to achieve somewhat functional vision for the first time in a long time with the new lens implant.”